CD8A and hepatocellular carcinoma: Tumor-infiltrating lymphocytes are a potential benefit of immunotherapy and enhance clinical response to cancer, and analysis of the T-cell population in hepatoma tissues revealed that the LAYN gene in infiltrating T cells can inhibit the function of regulatory T cells and CD8 T cells [10].